European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

9 EU fundings (€4,360,079): A CEllulaR immunoTherapy virtuAl twin for personalIsed cancer treatmeNT … Bdl Year 2023 EU Research and Innovation programme "Horizon"

Text

Siren 784257164

28/06/2023 EU funding (€1,500,000): Deciphering stem cell immunity
01/04/2023 EU funding (€10.8M): Impact of cell shapes on cell behaviour and fate
08/09/2023 EU funding (€195,915): Development and trafficking of type 1 and type 17 mucosal-associated invariant T cells
13/10/2023 EU funding (€2,499,999): Innovative Photoactivated Ruthenium Chemotherapy to treat eye cancer
24/02/2023 EU funding (€3,488,483): Real-Time high-content Super-Resolution Imaging of ES Cell States
01/07/2023 EU funding (€6,998,038): Autoantigen-specific adoptive regulatory T cell therapy against type 1 diabetes (ARTiDe)
01/06/2023 EU funding (€832,500): HOst-Transposon Interactions in the MAle GErmline
01/05/2023 EU funding (€9,984,080): COMPREHENSIVE CANCER INFRASTRUCTURES 4 EUROPE
01/12/2023 EU funding (€9,999,253): A CEllulaR immunoTherapy virtuAl twin for personalIsed cancer treatmeNT
CSV export

Investigative Journalism

Uncover International Corporate Connections
with our Free Investigative-Account

This filing was translated from to English. The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: Institut Curie, Paris, France.

Printing is only available to North Data premium service subscribers.